findmyKOL

Peter Goulden

Basic profile

Mount Sinai Hospital

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Peter Goulden is an Endocrinology/Metabolic physician affiliated with Mount Sinai Hospital. OpenAlex indexes 47 publications with 707 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
47publications

Distinct works indexed by OpenAlex, matched via ORCID.

707citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1111 Amsterdam Ave
New York, NY 100251716

Telephone

212-523-4000

Registry record last updated 18 Apr 2019.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    65.8%
    GLP-1 receptor agonist21%
    Ozempic57%Mounjaro18%Trulicity18%Rybelsus7%
    Part D<11 patients
    Biguanide (metformin)12.9%
    Metformin Hcl Er57%Metformin Hcl43%
    Part D34 patients

    + 7 more classes in this area

  • Hormonal (systemic)

    18.2%
    l-Thyroxine16.5%
    Levothyroxine Sodium83%Synthroid17%
    Part D51 patients
    Thyroid Hormone Synthesis Inhibitor1.7%
    Methimazole100%
    Part D<11 patients
  • Cardiovascular

    10.7%
    Statin5.5%
    Atorvastatin Calcium72%Rosuvastatin Calcium28%
    Part D<11 patients
    Peroxisome Proliferator-activated Receptor alpha Agonist1.9%
    Fenofibrate100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)38.2% facility · 61.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”